CRYOSITE LIMITED — Board/Management Information 2023

Apr 16, 2023

==> picture [169 x 39] intentionally omitted <==

ASX ANNOUNCEMENT

17 April 2023

APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR

Cryosite Limited ( ASX: CTE ) ( Company ) is pleased to announce the appointment of Mr Luis Antonio as an independent Non-Executive Director, effective from the date of this announcement.

Cryosite Limited Chair Steven Waller said: "Luis Antonio brings more than 20 years’ experience in the pharmaceutical and medical device industries to this role. He is an accomplished finance professional who, over the last 6 years, has held senior sales, marketing, and general management roles in international medical device companies. His experience and expertise complement Cryosite’s logistics and storage business".

Mr Antonio has professional interests in operations and finance excellence, new information systems and analytics, commercial collaboration and business strategy.

Previously, Mr Antonio has held positions as Head of Finance for Johnson & Johnson Medical Asia-Pacific, Vice-president of International Finance at Wright Medical, Vice-president Sales and Marketing Europe, MEA and Canada at Wright Medical, and Vice-president Asia-Pacific and MEA at Wright Medical. Mr Antonio is currently Area Vice-president Asia Pacific for Paragon28.

Mr Antonio holds a Bachelor of Arts in Finance and Economics (UNSW), a Bachelor of Arts in Accounting and Finance (CSU), an MBA (Curtin) and is a graduate of the Australian Institute of Company Directors. Mr Antonio is a CPA (Finance and Accounting).

Mr Antonio will stand for election as a director of the Company at the Company’s 2023 Annual General Meeting.

ENDS

Authorised by the Board of Cryosite Limited.

Cryosite Ltd | 13a Ferndell Street, South Granville NSW 2142| t: +61 (2) 8865 2000 | e: corporate@cryosite.com | www.cryosite.com